[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].
Personal experience in the treatment of Ischaemic Cerebrovascular Disease with platelet suppressant drugs is reported. 80 patients were treated with 5 different protocols: 1) group "A": dipyridamol (14 patients); 2) group "B": acetylsalicylic acid (ASA) (14 patients); 3) group "C": dipyridamol and ASA (22 patients); 4) group "D": ditazol (15 patients); 5) group "E": isoxsuprine resinate (15 patients) and followed-up for 22-34 months. The evolution of the disease is discussed and recurrences evaluated on the basis of initial clinical features and particular treatment given.
Caneschi
S
S
Bonaventi
C
C
Finzi
F
F
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001241:Aspirin / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007556:Isoxsuprine / Q000627:therapeutic use; D008297:Male; D010080:Oxazoles / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects*; D012008:Recurrence
D010080:Oxazoles; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D007556:Isoxsuprine; D001241:Aspirin
La malattia cerebrovascolare ischemica: il suo trattamento con differenti farmaci antiaggreganti piastrinici. Follow-up clinico di 80 pazienti (22-34 mesi).